EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adenosine-mediated immune responses in inflammatory bowel disease

Marta Vuerich, Du Hanh Nguyen, Davide Ferrari, Maria Serena Longhi

Frontiers in Cell and Developmental Biology · 12.08.2024 · 12

DOI: 10.3389/fcell.2024.1429736 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.08.2024. Verfasst von Marta Vuerich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular ATP and its derivates mediate a signaling pathway that might be pharmacologically targeted to treat inflammatory conditions. Extracellular adenosine, the product of ATP hydrolysis by ectonucleotidase enzymes, plays a key role in halting inflammation while promoting immune tolerance. The rate-limiting ectoenzyme ENTPD1/CD39 and the ecto-5′-nucleotidase/CD73 are the prototype members of the ectonucleotidase family, being responsible for ATP degradation into immunosuppressive adenosine. The biological effects of adenosine are mediated via adenosine receptors, a family of G protein-coupled receptors largely expressed on immune cells where they modulate innate and adaptive immune responses. Inflammatory bowel disease (IBD) is a serious inflammatory condition of the gastrointestinal tract, associated with substantial morbidity and often refractory to currently available medications. IBD is linked to altered interactions between the gut microbiota and the immune system in genetically predisposed individuals. A wealth of studies conducted in patients and animal models highlighted the role of various adenosine receptors in the modulation of chronic inflammatory diseases like IBD. In this review, we will discuss the most recent findings on adenosine-mediated immune responses in different cell types, with a focus on IBD and its most common manifestations, Crohn’s disease and ulcerative colitis.

Schlagwörter

Stichwörter der Autor:innen

ATPadenosineadenosine receptorsinflammationinflammatory bowel disease

Autor:innen und Institutionen

  • Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
  • Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Vuerich, M., Nguyen, D. H., Ferrari, D., & Longhi, M. S. (2024). Adenosine-mediated immune responses in inflammatory bowel disease. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1429736

Vancouver

Vuerich M, Nguyen DH, Ferrari D, Longhi MS. Adenosine-mediated immune responses in inflammatory bowel disease. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1429736

BibTeX
@article{Vuerich2024,
  author = {Vuerich, Marta and Nguyen, Du Hanh and Ferrari, Davide and Longhi, Maria Serena},
  title = {Adenosine-mediated immune responses in inflammatory bowel disease},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1429736}
}
Kostenlos starten →